https://charts.traderzeitung.de/phases/US8269171067
string(1417) "{"isin":"US8269171067","name":"SIGA Technologies Inc","stock_id_xnas":7874967,"stock_id_xnys":null,"generated_at":"2026-09-24 01:33:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.17,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.265,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":2.9968},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.26,"close_at":"2026-09-22 22:25:00","complete":true,"perf_pct":-0.1531}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.17,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-2.7607},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"
SIGA Technologies
Trading-Room

SIGA Technologies Aktie News & Nachrichten

[WKN: 919473 | Symbol: SIGA]
Realtimekurs
   
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Es konnten keine Nachrichten über SIGA Technologies gefunden werden.